[ad_1]
\n<\/p>\n
\u00a0<\/p>\n
New Delhi: High-quality generic drugs developed in India are helping to treat malaria, HIV-AIDS, and tuberculosis in developing countries at affordable prices, said Union Health Minister JP Nadda.<\/p>\n
The minister said this as he inaugurated the \u2018First Policy Makers\u2019 Forum\u2019, in the national capital, which will run till August 22.<\/p>\n
\u201cIndia has long been identified as the \u2018pharmacy of the world\u2019. We are proud that our generic drugs help to treat diseases like malaria, HIV-AIDS, and tuberculosis which are usually considered as the health problems of developing countries,\u201d Nadda said.<\/p>\n
He also emphasised India\u2019s commitment to the eradication of these diseases.<\/p>\n
\u201cThis contribution underscores India\u2019s commitment to global health and its responsibility in bridging the healthcare gap in developing nations,\u201d Nadda said.<\/p>\n
He also highlighted that \u201csince administering drugs for HIV-AIDS is very costly\u201d creating a burden for developing nations, \u201cthe Indian manufacturers took the lead in providing effective and affordable drugs\u201d.<\/p>\n
On vaccines, Nadda said that India has \u201calways been the world leader in the production and supply\u201d. The country contributes \u201cto approximately 60 per cent of the global supply of vaccines.\u201d<\/p>\n
The health minister said that even the World Health Organization (WHO) procures 70 per cent of its vaccine demand from India.<\/p>\n
He highlighted how India\u2019s Vaccine Maitri Programme supplied vaccines to several countries during the Covid-19 pandemic.<\/p>\n
At the forum, he also listed key health initiatives like the Jan Aushadhi Scheme \u2014 which aims to provide high-quality medicines at more affordable prices to all segments of society, especially the underprivileged.<\/p>\n
He also informed about the Ayushman Bharat scheme \u2014 the world\u2019s largest government-funded healthcare programme \u2014 providing assurance and insurance coverage for more than 500 million people for $6,000.<\/p>\n
Nadda said that India is collaborating with various countries in the health and pharma sector to improve global health.<\/p>\n
Meanwhile, the forum saw an international delegation of policymakers and drug regulators from 15 countries. It also featured the launch of innovative digital platforms for pharmacopoeia and drug safety monitoring.<\/p>\n
Nadda called the forum an \u201cexcellent opportunity to exchange views on the safety, efficacy, and quality of medical pharmaceutical products\u201d with countries.<\/p>\n<\/div>\n
[ad_2]
<\/p>\n","protected":false},"excerpt":{"rendered":"
[ad_1] \u00a0 New Delhi: High-quality generic drugs developed in India are helping to treat malaria, HIV-AIDS, and tuberculosis in developing countries at affordable prices, said Union Health Minister JP Nadda. The minister said this as he inaugurated the \u2018First Policy Makers\u2019 Forum\u2019, in the national capital, which will run till August 22. \u201cIndia has long […]<\/p>\n","protected":false},"author":1,"featured_media":41476,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[22],"tags":[],"class_list":{"0":"post-41475","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nation"},"jetpack_featured_media_url":"https:\/\/thenftimes.com\/wp-content\/uploads\/2024\/08\/Indian-generic-drugs-treating-malaria-HIV-AIDS-TB-in-developing-countries-says-Union-Health-Minister-JP-Nadda-1.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/thenftimes.com\/index.php\/wp-json\/wp\/v2\/posts\/41475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thenftimes.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thenftimes.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thenftimes.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thenftimes.com\/index.php\/wp-json\/wp\/v2\/comments?post=41475"}],"version-history":[{"count":1,"href":"https:\/\/thenftimes.com\/index.php\/wp-json\/wp\/v2\/posts\/41475\/revisions"}],"predecessor-version":[{"id":41477,"href":"https:\/\/thenftimes.com\/index.php\/wp-json\/wp\/v2\/posts\/41475\/revisions\/41477"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/thenftimes.com\/index.php\/wp-json\/wp\/v2\/media\/41476"}],"wp:attachment":[{"href":"https:\/\/thenftimes.com\/index.php\/wp-json\/wp\/v2\/media?parent=41475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thenftimes.com\/index.php\/wp-json\/wp\/v2\/categories?post=41475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thenftimes.com\/index.php\/wp-json\/wp\/v2\/tags?post=41475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}